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Abstract
Background: Obesity in women with polycystic ovary syndrome (PCOS) negatively affects all clinical features, and a 5 to
10% weight loss has shown promising results on reproductive, metabolic and psychological level. Incorporating a healthy
diet, increasing physical activity and changing dysfunctional thought patterns in women with PCOS are key points in losing
weight. The biggest challenge in weight management programs is to achieve a reasonable and sustainable weight loss.
The aim of this study is to explore whether Cognitive Behavioural Therapy (CBT) by a mental health professional, working in a
multidisciplinary team with a dietician and a physical therapist (a three-component intervention), is more effective for weight
loss in the long term, within 12 months. We will also explore whether mobile phone applications are effective in supporting
behavioural change and sustainable weight loss.
Methods: The present study is a longitudinal randomized controlled trial (RCT) to study the effectiveness of a three-
component 1-year cognitive-behavioural lifestyle intervention in overweight/obese women with PCOS. A total of 210
participants are randomly assigned to three groups: 1) CBT provided by the multidisciplinary team or; 2) CBT provided by
the multidisciplinary team and Short Message Service (SMS) or; 3) usual care: encourage weight loss through publicly
available services (control group). The primary aim of the 12-month intervention is to explore whether a three-component
1-year cognitive-behavioural lifestyle intervention is effective to decrease weight, when compared to usual care. Secondary
outcomes include: the effect of the intervention on the PCOS phenotype, waist circumference, waist to hip ratio, ovulation
rates, total testosterone, SHBG, free androgen index (FAI), AMH, hirsutism, acne, fasting glucose, blood pressure and all
psychological parameters. Additionally, we assessed time to pregnancy, ongoing pregnancies, clinical pregnancies,
miscarriages and birth weight.
All outcome variables are measured at the start of the study, and again at 3 months, 6 months, nine months and 12 months.
Discussion:We expect that CBT provided by a multidisciplinary team, especially combined with SMS, is effective in
developing a healthy lifestyle and achieving a long-term weight loss in women with PCOS. Losing 5– 10% body weight
improves various PCOS characteristics. Consequently, we expect to show that CBT provided by a multidisciplinary team
improves reproductive and metabolic outcomes, as well as quality of life, while at the same time being cost-effective.
(Continued on next page)
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Plain English summary
Obesity in women with polycystic ovary syndrome (PCOS)
negatively affects all clinical features, and a 5 to 10% weight
loss has shown promising results on reproductive, meta-
bolic and psychological level. Incorporating a healthy diet,
increasing physical activity and changing dysfunctional
thought patterns in women with PCOS are key points in
losing weight. The present study is a longitudinal random-
ized controlled trial (RCT) to study the effectiveness of a
three-component 1-year cognitive-behavioural lifestyle
intervention in overweight/obese women with PCOS. We
will also explore whether mobile phone applications are ef-
fective in supporting behavioural change and sustainable
weight loss. The primary aim of the 12-month intervention
is to explore whether a three-component 1-year cognitive-
behavioural lifestyle intervention is effective to decrease
weight, when compared to usual care. We expect that CBT
provided by a multidisciplinary team, especially combined
with SMS, is effective in developing a healthy lifestyle and
achieving a long-term weight loss in women with PCOS.
Losing 5– 10% body weight will improve various PCOS
characteristics. Consequently, we expect to show that CBT
provided by a multidisciplinary team improves reproductive
and metabolic outcomes, as well as quality of life, while at
the same time being cost-effective in women with PCOS.
Background
Polycystic ovary syndrome (PCOS) is a common endocrine
disorder that affects 5–10% of women in their reproductive
years [1]. According to the ESHRE/ASRM Rotterdam con-
sensus [2], the diagnosis of PCOS requires at least 2 of the
following 3 criteria: oligoovulation or anovulation (irregular
or no menstrual cycle at all), clinical (hirsutism) and/or
biochemical signs of hyperandrogenism (elevated free an-
drogen index or elevated testosterone levels), polycystic
ovarian morphology (on ultrasound), and the exclusion of
other aetiologies that might cause hyperandrogenism.
PCOS women will generally experience one or more of the
following symptoms in varying degrees: hirsutism (exces-
sive body hair growth), acne, anovulatory infertility, obesity,
insulin resistance and dyslipidaemia [2, 3].
The incidence of overweight and obesity in PCOS
women is between 50 and 60% [3]. The prevalence of
obesity in the general population is increasing, and this
might result in an even higher incidence of PCOS in the
future [4, 5]. The current prevalence of overweight and
obesity is significantly higher in PCOS women, especially
in Caucasian women [6]. Overweight in women with
PCOS negatively affects all clinical features [3, 7–9] and
gaining weight aggravates also psychological aspects.
Women with PCOS report a major impact on their quality
of life (QoL) due to PCOS symptoms [10, 11] and experi-
ence more distress compared to women without PCOS
[12]. Weight concerns in particular appear to have the
largest impact on QoL, compared to other PCOS symp-
toms such as amenorrhea, oligomenorrhea, hirsutism and
acne [13]. Obesity is also a risk factor for lower self-
esteem and greater sexual dissatisfaction in women with
PCOS, compared to age matched controls [14, 15]. PCOS
women with amenorrhoea seem to have lower levels of
self-esteem and greater fear of negative appearance com-
pared to PCOS women with oligo-amenorrhea [16].
Whether PCOS women have a unique predisposition to
obesity is not yet clear [17]. A recent study by Louwers et
al, looking into the genetic predisposition for overweight
or obesity, did not discover any differences in the number
of risk alleles for obesity between women with PCOS and
the controls [18]. Although women with PCOS generally
do have a healthy diet, they seem to have a higher caloric
intake and are physically less active, compared to controls
without PCOS [19]. Also, women diagnosed with PCOS
more often use a self-initiated inadequate diet than con-
trols [20]. Insulin resistance might play a mediating role in
the effect of obesity on metabolic and reproductive symp-
toms in PCOS [21]. Other authors do suggest that the
high prevalence of obesity might be a result of selection
and referral bias of obese PCOS women [22]. In summary,
much about the link between PCOS and obesity remains
unknown [1]. It is still unclear whether obesity is the
cause, or an effect of the disease itself [6, 23].
There is a large number of small (one or two-component)
studies demonstrating that losing 5 to 10% of initial body
weight improves reproductive, metabolic and psychological
features in PCOS women [24]. Moreover, it often leads to
ovulation and subsequent pregnancy, [7, 25–27] as well as a
reduction in miscarriage rates in PCOS women [4, 7].
Weight loss also reduces the risk of Type II Diabetes
Mellitus and the incidence of the metabolic syndrome in the
long term [7, 27]. Additionally, studies have indicated that
decreasing intra-abdominal fat tissue in particular results in
the restoration of ovulation [28], even when women remain
within their World Health Organisation (WHO) weight
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class after weight loss [29, 30]. Recent work from Mutsaerts
et al [31] and Dokras et al [32] showed different results. A
mean weight loss of 4.4 kg following a two-component
lifestyle treatment of 26 weeks did not result in a significant
difference in live birth rates compared to a weight loss of
1.1 kg in the control group. Also, there was no difference in
pregnancy and neonatal complications between groups [31].
Weight loss by the Look AHEAD protocol (16 weeks) or
the use of the oral contraceptive pill shows significant im-
provement in both groups at physicial and mental domains
related to quality of life, depression and anxiety [32]. At the
ESHRE/ASRM PCOS meeting in 2010, a consensus was
reached that lifestyle should be optimized before conception
[23] to improve the effectiveness of fertility treatment [33,
34] and to improve (mental)health across a woman’s lifespan
as well as that of her child to be [27]. However, no inter-
national evidence based protocol exists for the long-term
treatment of overweight and obesity in this particular group
of obese women [35].
The biggest challenge in weight management programs
is to achieve a reasonable and sustainable weight loss [36,
37]. Many obesity interventions compare one-component
(physical activity or nutrition intervention) with two-
component (physical activity and nutrition or nutrition
and counselling) interventions. Three-component (phys-
ical activity, nutrition and counselling) lifestyle interven-
tions seems to have the biggest effect, compared to one or
two components [38]. Weight loss programs in general
seem to be effective in the short term [39]; however, most
of the initial weight loss is regained within 1 year [36].
Long term weight-loss seems the biggest challenge for the
“global obesity epidemic” according to the WHO [40].
Incorporating a healthy diet, increasing physical activity
and changing dysfunctional thinking patterns in women
with PCOS are key points in losing weight [41]. However,
treatment adherence is often low [36] and drop-out rates
are high. The longer the treatment, the higher the chance
for participants to drop-out, and indeed the highest drop-
out rates are reported in interventions that last 24 weeks
or longer [42]. This relation between the drop-out rate
and the duration of therapy is particular worrying, as long
lasting lifestyle changes are preferred. Patients who are
likely to drop out will benefit most from adherence to a
long-term lifestyle program compared to patients not at
risk to drop out. Fauser et al. commented that more
research is needed to optimize lifestyle interventions,
maximizing weight loss and minimizing drop-out rates for
PCOS women with a wish to conceive [23].
A possible solution to increase therapy adherence
and reduce the drop-out rate is support by mobile
phone applications. Weight loss interventions making
use of internet and mobile phone applications have
emerged to induce behavioural changes [43]. There is
a growing body of literature on Short Message Service
(SMS) and smart phone interventions for obesity
treatment, indicating that tailored text messages are
more effective than generic ones [44, 45]. Smart
phone and mobile phone applications seem effective
when embedded in an intervention program [46].
Studies have indicated that sending SMS results in
weight maintenance up to 12 months after comple-
tion of cognitive behavioural treatment (CBT), [47]
and supports controlling the desire to eat and pro-
moting an active lifestyle [48]. Moreover, the use of
SMS has shown to improve adherence and decrease
the drop-out rates in weight loss treatments [49],
which is associated with improvement in weight-
related behaviours and weight outcomes [50].
Fauser et al. commented that more research is
needed to optimize lifestyle interventions, maximizing
weight loss and minimizing dropout for PCOS women
with a wish to conceive [23].
Methods/design
Aim
The aim of this study is to examine whether CBT, pro-
vided by a mental health professional working in a
multidisciplinary team with a dietician and a physical
therapist (a three-component intervention), is effective
to decrease weight, compared to usual care at the end of
treatment in obese women with PCOS. Furthermore, we
explore whether mobile phone applications are effective
in supporting behavioural change and sustainable
weight loss.
Research hypotheses
Primary:
1) A multidisciplinary 1-year cognitive-behavioural lifestyle
intervention (with or without SMS) is more effective to
decrease weight in 12 months, compared to usual care.
Secondary:
2) A multidisciplinary 1-year cognitive-behavioural
lifestyle intervention (with or without SMS) is
effective to decrease weight by 4.0 BMI points at
12 months, compared to usual care.
3) SMS maintenance treatment in combination with a
multidisciplinary 1-year cognitive-behavioural lifestyle
intervention is more effective than the multidisciplinary
1-year cognitive-behavioural lifestyle intervention alone,
in terms of weight loss maintenance and drop-out
reduction.
4) A multidisciplinary 1-year cognitive-behavioural
lifestyle intervention (with or without SMS) is
effective in improving the menstrual cyclicity as
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well as anthropomorphometric, ultra-sonographic,
endocrine and psychological parameters in women
with PCOS.
Design
The present study is a longitudinal RCT measuring
the effectiveness of a three-component multidisciplin-
ary 1-year cognitive-behavioural lifestyle intervention
in overweight/obese women with PCOS. It is a three-
armed RCT comparing three groups: 1) CBT provided
by a multidisciplinary team or; 2) CBT provided by a
multidisciplinary team and Short Message Service
(SMS) or; 3) usual care: encouraged to lose weight by
publicly available services (control group), see Fig. 1.
Patients will be included in the trial at the depart-
ment of Obstetrics and Gynaecology of the Erasmus
MC in Rotterdam, the Netherlands.
Participants
Women with menstrual cycle disorders are systematically
screened using the same standardised protocol i.e. the so
called CyclusOLigoAmenorroe (COLA) protocol. The
COLA protocol includes a family and reproductive history,
antropomorphometric, ultrasonographic assessments and
screening. Based on this screening, women are diagnosed
according the World Health Organisation (WHO) classifi-
cation. Women with WHO 2 normogonadotropic normo-
estrogenic anovulation are further classified using the
Fig. 1 CONSORT 2010 standard RCT flow diagram
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Rotterdam consensus criteria for PCOS and non-PCOS.
Patients who meet the inclusion and exclusion criteria
(shown in Table 1) are eligible. At enrolment, all patients
receive detailed information about the role of weight loss in
PCOS and the benefits of lifestyle modification.
The gynaecologist presents the patient information
about the study using a patient information leaflet. After
2 weeks, patients are contacted by telephone in order to
assess whether they are willing to participate in the
study. In order to participate, patients need to sign the
informed consent form and return it by regular mail. As
soon as this form is received out our research office,
appointments for baseline measurements are made.
Randomisation
At the baseline, after the initial assessment, participants
are randomized at a 2:1 ratio into the following groups:
1-year CBT lifestyle intervention with SMS (n = 78), 1-
year CBT lifestyle intervention without SMS (n = 78), or
the control group who receives usual care (n = 78) using
a computer-generated random numbers table. A re-
search nurse, who is not involved in the study, carries
out the randomisation. Assignment is made by sequen-
tially numbered, identical, sealed envelopes, each
containing a letter designating the allocation (i.e. “A” for
intervention with SMS, “B” for intervention without
SMS and “C” for control,).
Intervention
The 1-year multidisciplinary lifestyle intervention aims at:
1) changing cognitions; 2) changing dietary habits; 3)
encouraging and promoting physical activity; and 4) acti-
vating social support; and consists of twenty 2.5 h group
sessions. The first 1.5-h of every group session is super-
vised by a mental health professional and a dietician. The
last hour of each session is supervised by a physical ther-
apist. Each lifestyle intervention group consists of a max-
imum of 10 patients to ensure that there is sufficient
individual attention for every participant. Additionally,
participants receive five individual counselling sessions of
45 min with a mental health professional, five individual
sessions with a physical therapist and five with a dietician.
We developed the “PCOS lifestyle textbook” for partici-
pants, which describes the activities of each group session
and the homework assignments. To standardize the treat-
ment and to facilitate the therapist’s treatment adherence,
we developed a therapist manual, which includes proto-
cols for each session. The manual also includes Power-
Point slides to present at each group session.
Phase 1: first 3 months (session 1 to 11)
We divided the 20 group sessions into four phases. The
outline of each session is presented in Table 2. In the first
phase of the program, the group sessions are held weekly.
CBT techniques are used to create awareness and to
restructure dysfunctional thoughts about lifestyle (food &
exercise), weight (loss) and self-esteem. The Dutch food
guide (DFG) is used as a guideline for healthy eating and is
the main guideline during the nutritional sessions run by
the dietician. Subjects receive the DFG guide for women
aged 19 to 50 (Table 3) [51]. Based on the DFG, a healthy
woman with a normal weight and regular exercise, may
take in up to 2000 kilocalories in total, consisting of 1700
kilocalories for breakfast, lunch and dinner, and another
300 kilocalories for (healthy) snacking. The take-up of 2000
kilocalories in total is normally advised for weight mainten-
ance. Hence, for most women in the lifestyle program this
(reduced intake) will result in weight loss. During phase 1,
we emphasize that participants should start making healthy,
sustainable food choices and to avoid “restrained” behav-
iour like skipping meals and reducing food variance [52].
The physical therapist encourages participants to use
exercise as part of their daily routine, [53] according to
the Global Recommendations for physical activity by the
World Health Organisation, [54] and advises:
– To do 5 days of moderate physical activity for
30 min each day; and
– To do vigorous exercise 1 to 3 days a week, for at
least 20 min per session; and
– To perform 8 to 10 muscle-strengthening activities
involving major muscle groups twice a week.
Phase 2: month 3 to 6 (session 12 to 16)
In the second phase of the program, the group sessions
are held once every two weeks. During this phase partici-
pants are motivated to develop a structured eating pattern
to avoid over-restriction and under-restriction, like binge
eating and restrained eating [55]. The frequency of face-
to-face contact decreases over time, to stimulate partici-
pants to maintain healthy eating and physical activity. This
is based on the principles of ‘proactive coping’ to promote
Table 1 Eligibility
Inclusion criteria: Exclusion criteria:
✓PCOS according to Rotterdam
consensus criteria [2]
✓Women with inadequate command
of the Dutch language
✓Body mass index (BMI)
> 25 kg/m2
✓Mental illness
✓Age between 18 and 38 years ✓Obesity with another somatic cause
✓Trying to conceive over 1 year ✓Ovarian tumours that lead to an
androgen excess
✓Adrenal diseases
✓Other malformations of internal
genitalia
✓Pregnancy
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self-regulation [56]. Also, behavioural skills developed dur-
ing phase 1 of the intervention are reinforced [57].
Phase 3: month 6 to 9 (session 17 to 19)
In the third phase of the program, the group sessions are
held once a month. Participants learn about relapse man-
agement and maintenance of their weight loss. By using
proactive coping, participants set new goals for the next 3
months aimed at maintaining a healthy lifestyle. Individual
counselling sessions are planned if needed at the request
of the participant.
Phase 4: final 3 months (session 20)
During the final 3 months of the program, there are no
scheduled group sessions. Participants can contact the
Table 2 Overview of the content of the lifestyle intervention
Session Topic Objectives
1 Introduction Introduction of the therapists and the group members.
Agreement on attendance, commitment, homework assignments,
privacy and buddy system.
Providing information about the program and target weight.
Providing information about the concept of energy balance.
Explaining the link between thoughts, feelings and behaviors.
2-4 Diet: Explaining the Dutch food guide and daily amounts
Psychology: introduction of cognitive behavior therapy
Providing information about the Dutch Food Guide (DFG).
Increasing or decreasing daily amounts based on the Dutch
Food Guide (DFG)
Identifying unhealthy food choices.
Understanding the rationale of cognitive behavior treatment.
Completing a thought record. Setting realistic goals (proactive coping).
5 Partner and social support meeting Welcome to spouses (or family/friends)
General introduction of the lifestyle program for spouses
(or family/friends).
How to be supportive in a helpful way.
Providing information about the concept of energy balance.
6,7 Diet: Reading food nutrition labels
Psychology: Biased perception and interpretation
Participants are able to read food nutrition labels.
Making healthier choices based on food nutrition labels.
Identifying and correcting biased perception and interpretation.
8 Dealing with infertility Sharing emotions concerning infertility.
Reframing negative thoughts concerning infertility.
9,10 Binge eating Learning different incentive values of food.
Obtaining a regular eating pattern (breakfast, lunch and dinner).
Knowing the difference about hunger, appetite sensations and
binge eating.
11 Partner and social support meeting Using different preparation techniques for cooking.
Asking help from spouses.
12 Binge eating Finding alternate ways to handle binge eating
Eating healthy portion sizes.
13 Diet: dealing with the holidays or special occasions
Psychology: Behavioral experiment
Making a meal plan for the holidays.
Explaining the rationale for behavioral experiments.
Setting up behavioral experiments.
14 Mindful eating Knowing the difference between conscious and unconscious eating.
Introduction of mindfulness techniques.
15 Diet: Snacks
Psychology: Relapse prevention
Learning the difference between healthy and unhealthy snacking.
Identifying difficult moments and finding alternative thoughts.
Reframing dysfunctional cognitions concerning relapse.
16 Diet: Eating in a restaurant
Psychology: assertiveness
Eating a healthy meal in a restaurant.
Performing a roll-playing game in a restaurant.
Saying no in a food related situation.
17 Partner and social support meeting Doing the healthy eating quiz.
Doing a cue exposure exercise involving sweets and cookies.
18,19 Diet: Healthy pregnancy
Psychology: Relapse prevention
Identifying and preventing relapse moments.
Developing self-efficacy beliefs for the future.
Dealing with food and appetite sensations during pregnancy.
20 Evaluation of the program
Relapse prevention
Evaluation of the lifestyle program and participants progress.
Providing information about long-term weight maintenance.
Coping with regaining weight.
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multidisciplinary team if individual counselling sessions
are needed.
There is an outreach policy to motivate participants to
come to the measurement sessions, unless the partici-
pant indicates to withdraw from the study. Participation
in the lifestyle intervention terminates if the participant
misses more than 3 out of 20 group sessions. In such
cases, the measurements will also stop. For obvious rea-
sons, the intervention and the measurements will also
stop when the participant is pregnant.
Maintenance intervention by SMS
At the 3 month point, participants are randomly assigned
to SMS support or CBT without SMS support. Partici-
pants will be sending weekly self-monitored information
regarding their diet, physical activity and emotions by
SMS to the mental health professional for the next
9 months (Table 4).
A semi-automated software program generates feedback
in response to the incoming messages. These feedback
messages provide social support, encourage positive
behaviour and empower behavioural strategies. The
mental health professional assesses whether the suggested
feedback is applicable before sending it to the participant.
In addition, participants receive two messages per week
addressing eating behaviour (self-monitoring, barriers,
binge eating, eating pace, emotional eating, food choices,
portions, planning, preparation, stimulus control, social
eating, sugar sweetened beverages) and physical activity
(motivation, fun facts, sedentary behaviour). There are five
types of messages, as shown in Table 5.
Control group: usual care
Just like the lifestyle intervention group, the control
group visits the hospital after the initial assessment dur-
ing the 4 consecutive occasions at which they are simi-
larly assessed as the CBT lifestyle intervention group.
During these 5 measurement moments they have a
short, unstructured consult with their treating physician.
Participants in the control group are encouraged to lose
weight through publicly available services (i.e. diets, vis-
iting a dietician, going to the gym or participating in
public programs such as Weight Watchers®) and use
simple strategies, including self-monitoring of their diet.
The physician also mentions the risk of overweight for
both mother and child, and the relation between over-
weight and fertility. If patients fail to achieve their target
weight during the 12-month study period (see below),
they can participate in the lifestyle intervention, but are
not included in the trial.
Table 3 Dutch Food Guide (women, age group 19–50 years)
Vegetables 200 g
Fruit 200 g (2 servings)
Bread 6 slices
Potatoes, rice, pasta or beans 200 g
Milk 450 ml
Cheese 1,5 slice
Meat 100 g
Butter and oil 30 g
Drinks 1,5 liter
(Healthy) Snacks 300 calories
Table 4 Text message plan
1) How many hours of exercise did you had in the past week?
For example cycling or walking
A) Less than 1 h
B) 1 to 3 h
C) 4 to 6 h
D) 7 to 10 h
E) More than 10 h
2) How many days did you keep up a healthy diet in the past week?
A) None of the 7 days
B) 1 to 2 days
C) 3 to 4 days
D) 5 to 6 days
E) All 7 days
3) How often did you felt satisfied about yourself in the past week?
A) Never
B) Almost never
C) Sometimes
D) Often
E) Always
4) How often did you felt sad or unhappy in the past week?
A) Always
B) Often
C) Sometimes
D) Almost never
E) Never
5) What is your weight today in kilograms?
For example 88,4 kg
Table 5 Types of text messages
• Tips (i.e. Going grocery shopping today? Don’t go if you’re hungry!)
• Reminders (i.e. Read the flyer about the Dutch food guide again.
What’s your focus this week?)
• Educational facts (i.e. Did you know that cleaning the house is also
a moment of exercise? You can burn up to 140 calories in an hour!)
• Motivational messages (i.e. Are you not completely satisfied with
your diet today? Tomorrow is new day, don’t give up!)
• Knowledge based (i.e. Do you know the second step in writing
a thought record?)
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At the Erasmus MC, patients diagnosed with PCOS
receive ovulation induction treatment when shifted to a
lower BMI category. Meaning: 1) a weight loss of 4.0
BMI points; 2) a BMI < 34.0; and 3) weight loss mainten-
ance over 3 months. The intervention group receives
ovulation induction treatment after 1) a weight loss of
4.0 BMI points; 2) a BMI < 34.0; and 3) complying with
the intervention group for more than 1 year.
Outcome measures
The primary outcome of this study is to test whether CBT
provided by a mental health professional, working in a
multidisciplinary team with a dietician and a physical ther-
apist (a three-component intervention), is effective to
decrease weight compared to usual care (control) at the
end of the treatment. Secondary outcomes include: repro-
ductive, drop-out, quality of life, healthy diet, physical
activity, metabolic and endocrine improvements, the
health of the (unborn) child. All outcome variables are
measured at the start of the study, and again at 3 months,
6 months, 9 months and 12 months. All outcome mea-
sures are displayed in Table 6. Below we give more details
about the collection of the secondary outcomes.
Psychological outcomes
Eating behaviour and disorders The Dutch Eating Be-
haviour Questionnaire (DEBQ) is a validated question-
naire; it is administered to assess restrained eating (10
items), emotional eating (13 items), and external eating
(10 items). Subscales are computed as the mean of the
relevant questions resulting in a score between 1 and 5,
with a higher score reflecting a higher degree of the
relevant eating behaviour [58]. Additionally, the Eating
Disorder Examination Questionnaire (EDE-Q) is used to
measure specific eating disorders. This questionnaire
consists of 36 items measuring five subscales: concerns
about shape, weight, and eating, in addition to restrained
and binge eating. The subscale scores range between 0
and 6. A higher score indicates more severe eating
psychopathology [59].
Table 6 Outcomes measures (T0, T1, T2, T3, T4)
Primary outcome
Weight in kilograms
Secondary outcomes
(1) reproductive outcomes: a) cycle duration and frequency
b) spontaneous pregnancies
2) anthropomorphometric
outcomes:
a) BMI
b) waist circumference (WC)
c) hip circumference (HC)
d)WC/HC ratio
(3) clinical and biochemical
PCOS features:
a) hair growth pattern
- Ferriman Gallwey score
b) blood pressure
c) transvaginal ultrasound outcomes
- ovarian volume
- follicle count
- total follicles per ovary
d) endocrine outcomes
- insulin resistance
- hyperandrogenism
- dyslipidemia
(4) psychological
outcomes:
a) eating behaviour and disturbances
- The Dutch Eating Behaviour
Questionnaire (NVE)
- Eating Disorder Examination
Questionnaire (EDE-Q)
b) quality of Life
- Short Form 36 (SF-36)
- Polycystic Ovary Syndrome
Questionnaire (PCOSQ)
c) depression
- Beck Depression Inventory (BDI)
d) self-esteem
- Rosenberg Self Esteem Scale (RSE)
e) fear of negative appearance
- Fear of Negative Appearance
Evaluation Scale (FNAES)
f) satisfaction
- Self-constructed questionnaire
(5) physical activity: a) perceived level of daily physical activity
- the International Physical Activity
Questionnaire (IPAQ)
b) the intervention group: submaximal
bicycle test
(5) physical activity: a) food intake
-energy (calories)
- protein
- fat
Table 6 Outcomes measures (T0, T1, T2, T3, T4) (Continued)
- saturated fat
- carbohydrates
- mono- and disaccharides
- drinks (ml)
(7) other: - attendance at meetings
- drop-out and reasons for drop-out
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Quality of life The Short Form 36 (SF-36) is a generic
quality of life questionnaire that consists of 36 questions.
Quality of life is divided into in eight dimensions: phys-
ical functioning, role-physical, bodily pain, general
health, vitality, social functioning, role-emotional and
mental health. The sum of the SF-36 item scores within
each dimension is transformed into a scale ranging from
0 (poor health) to 100 (good health) [60].
The Polycystic Ovary Syndrome Questionnaire (PCOSQ)
is a specific health-related quality of life (HRQoL) ques-
tionnaire for PCOS women [13]. This questionnaire con-
sists of 26 questions and five domains: emotions, body
hair, weight, infertility and menstrual problems. Each
item is scored on a scale between 1 and 7, whereby 1 in-
dicates the worst health status and 7 denotes best health
status. We have translated this questionnaire into Dutch.
This questionnaire has not yet been validated.
Depression The Beck Depression Inventory (BDI) [61]
is a validated questionnaire that measures depression
and depressive symptoms according to the criteria of the
DSM-IV [62]. The Dutch BDI-II [63] questionnaire con-
sists of 21 questions for the evaluation of cognitive,
affective and somatic symptoms of depression. Higher
total scores indicate more severe depressive symptoms.
Self-esteem and body image Self-esteem is measured
by the Rosenberg Self Esteem Scale. This questionnaire
consists of 10 questions and has been validated for the
Dutch population [64]. The RSES measures global self-
esteem. Items are scored on a 4-point scale. Scores
below 21 indicate low self-esteem. The Fear of Negative
Appearance Evaluation Scale (FNAES) [65] is a short
questionnaire consisting of six items that measure body
image, eating disorder and depression. The items are an-
swered on a five-point Likert scale, ranging from ‘not at
all’ to ‘extremely’, whereby a higher score indicates more
fear of negative evaluation by others. The Dutch version
has not been validated yet.
Dietary outcomes
Food intake is documented at home on paper, in a 3 day
(including 1 weekend day) food diary to determine changes
over time in food intake, meal and eating pattern, meal fre-
quency, amount of carbohydrates, vegetables, fruit, dairy
and snacks. Additionally, using a self-constructed question-
naire according to the dietary history method [66], partici-
pants are asked about:
 Weight: i.e. birth weight, highest weight,
development of obesity
 Dieting: i.e. history of weight loss dieting and how
much weight loss was achieved
 History of eating: i.e. how parents dealt with food
while growing up
 Eating pattern: i.e. watching TV while eating,
amount of take-out foods
The validity of the dietary history method during
weekdays has been proven, and it is less reliable during
weekends [67].
The Dutch Food Composition Database (NEVO) is
used to calculate the nutritional composition of each
3 day food record. This database contains information
on food products and meals that are regularly eaten by a
large proportion of the Dutch population.
Physical activity outcomes
To gain insight into the perceived level of daily physical ac-
tivity, we use the International Physical Activity Question-
naire (IPAQ) [68]. This questionnaire consists of 31 items
about the frequency and duration of physical activity at
work, during transportation, during household activities
and during leisure time in the course of the previous week.
A continuous progressive submaximal test is used to de-
termine the exercise intensity and the fitness progress in
the intervention group. The maximum heart rate and the
maximum load are determined during this test. Firstly, the
resting heart rate is measured when sitting in a chair. Sec-
ondly, the heartrate is measured using a standard ramp
protocol on a bicycle after a 5 minute warm-up (20 watt)
on a bicycle. Thirdly, the load is increased every minute
with 10, 15 or 20 watt, based on the level of the participant.
During the test, the participant must maintain a speed of
60 to 80 revolutions per minute. The test is stopped when
the speed is decreased by 15 revolutions per minute. The
response to the submaximal test is evaluated immediately
after the test by the modified Borg scale [69]. This scale
ranges from 0 to 10 and provides insight into the perceived
exertion level.
Prior to the submaximal test, the treating physician
will examine contraindications (cardiac and/or pulmon-
ary problems) using the Physical Activity Readiness
Questionnaire (PAR-Q) [70]. In case of the slightest sus-
picion of cardiac and/or pulmonary problems the sub-
maximal test is not performed.
Sample size calculation
The original sample size calculation in 2009 was based
on an anticipated effect of a difference between the
groups of 0.45 in terms of Cohen’s d in the primary out-
come variable (BMI), with a power (1-beta) of 0.80 and
an alpha level of 0.05 (two-sided) in a 2:1 ratio. This ra-
tio was required for analysis of the secondary outcome:
the effect of SMS within the intervention group. This re-
sulted in 156 patients to be enrolled in the intervention
group and 78 patients in the control group, a total of
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234. This number was registered at the Dutch Trial
Registry (TC 2450). On behalf of the Grant Foundation
(MRace), an interim analysis was performed in May
2014. After inclusion of 150 patients, we applied an in-
terim power analysis to the complete cases. The control
group had a reduction from 33.3 ± 6.8 kg/m2 to 32.6 ±
6.6 kg/m2, an effect of Cohen’s d = 0.10, whereas the life-
style intervention group showed a reduction from 33.8 ±
4.8 kg/m2 to 31.3 ± 5.1 kg/m2, an effect of d = 0.52 and a
difference of 0.42. For the sample size calculation, we
applied the method described by Aberson [71], with a
power of 0.90, a two-sided alpha of 0.025 (corrected for
the interim analysis) and five repeated measures linearly
decreasing. We observed an intercorrelation of about
0.90 between all measurements. Maintaining a ratio of
2:1, the required sample is 84 participants in the lifestyle
intervention and 42 in the control group, a total of 126
complete cases. With an observed drop-out proportion
of 40%, a total of 210 participants are needed for the
study. We anticipated to have a relatively high drop-out
rate, because pregnancy leads to exclusion. Note that
this sample size calculation is a conservative number, as
it is based on a complete case analysis of variance. The
intended multilevel analysis provides more power.
Statistical analyses
Mixed modelling will be applied for longitudinal analyses of
the data by using SPSS version 21. Mixed modelling can ef-
ficiently deal with missing data and unbalanced time-points
[72]. This analysis will include two levels: the patients will
constitute the upper level, and their repeated measures the
lower level. First, for each outcome variable a saturated
model will be postulated, with the primary or/and second-
ary outcomes as dependent variables. The saturated models
will include treatment group, time, quadratic time, loga-
rithm of time, and all treatment-time interactions as fixed
effects. The deviance statistic [73] using restricted
maximum likelihood [74] will be applied to determine the
covariance structure. Next, the saturated fixed part of the
models will be reduced by eliminating insignificant fixed
effects using Wald tests, respecting that interaction effects
must be nested under their main effects [75]. The signifi-
cance of the difference between the saturated models and
the parsimonious final models will be determined with the
deviance statistic using ordinary maximum likelihood. The
residuals of the model will be checked for normal distribu-
tion, which is necessary for a correctly fitted mixed model.
Effect sizes will be calculated by dividing the differences
between time-point and baseline estimations and the esti-
mated baseline standard deviation. The definition of Cohen
will be used for the interpretation of the effects sizes: an
effect size of 0.20 is considered a small effect, 0.50 medium
and 0.80 a large effect [76].
Discussion
This paper outlines the protocol of a study evaluating the
effectiveness of an intensive 1-year multidisciplinary lifestyle
intervention for overweight/obese women with PCOS.
Weight loss through lifestyle modification before starting
fertility treatment is described as the first step for over-
weight/obese PCOS women who are trying to conceive
[23]. However, no international evidence based protocol ex-
ists describing the design of a three-component lifestyle
modification program. This is the largest RCT investigating
the effectiveness of a multidisciplinary cognitive- lifestyle
intervention in overweight/obese women diagnosed with
PCOS. The present study started in September 2009 and
the first results are expected in December 2016.
One of the strengths is the selection criterion that not
only PCOS women in obesity class III, but also in obesity
classes I and II, as well as overweight women are included
in this study. All PCOS patients with a BMI > 25 kg/m2
who are eligible for ovulation induction treatment are ob-
ligated to follow the lifestyle modification protocol prior
to fertility treatment. Therefore, study inclusion is not
biased by weight loss motivation as in most research, as
weight loss is compulsory for treatment at the Erasmus
MC. This enhances the generalizability of our findings;
however, this might result in higher drop-out rates.
Another strength is the length and intensity of this
three-component lifestyle modification program. This 1-
year program combines several evidence based elements:
cognitive behavioural techniques, a multidisciplinary team,
and long term support. Indeed, a recent study demon-
strated that a non-invasive (two-component) 6-month
weight-loss intervention preceding infertility treatment
did not result in reasonable weight loss [31]. Also, the use
of the oral contraceptive pill improves quality of life com-
pared to lifestyle treatment [32]. Research supports that
combining a healthy diet, increasing physical activity and
behavioural modification through CBT is the best strategy
for long-term weight loss [38, 41]. In addition, the SMS
aims at increasing weight maintenance success and de-
creasing drop-out rates. As treatment adherence is often
problematic [36, 42], SMS is a promising e-health tool to
enhance adherence rates [50].
The goal for every participant is to achieve relevant reduc-
tion of at least 4.0 BMI points. The fertility treatment cut-off
at the Erasmus MC in Rotterdam is set at 34 kg/m2. That
means that not all women who achieve a reduction of 4.0
BMI are eligible for further fertility treatment at the Erasmus
MC. We could have chosen to include this cut-off as the
criterion of the primary outcome. In that case, participation
would be considered a success if the weight loss was at least
4.0 BMI points AND the BMI was below 34 kg/m2. We
chose not to include this cut-off at 34 kg/m2, because there
is no consensus about the height of such threshold. Inclu-
sion of this ad hoc threshold would therefore hamper the
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generalizability of the study. Moreover, it was considered
unrealistic to expect that participants would be able to re-
duce more than 4.0 BMI in one year. If the participant was
still above 34 kg/m2 after one year of treatment, the partici-
pant was encouraged to continue weight loss on their own,
using the skills and attitude learned in the intervention.
Obesity increases the costs and decreases the effective-
ness of fertility treatment in PCOS women [77]. The costs
of this lifestyle intervention are relatively low, compared
to increased medical costs in PCOS women without
weight loss, as fertility treatment success is lower and the
risk of pregnancy complications is higher [78].
Obesity is considered to be a multi-factorial problem;
therefore, a more tailored intervention for subgroups, be-
yond using the BMI, is needed [79]. Recent research indi-
cates that weight loss in the first 2 months is a good
predictor for outcomes after 1 year of lifestyle intervention
[80, 81]. Hence, identifying individuals at risk for being un-
successful or those being successful, and providing tailored
treatment, might be the solution for successful long-term
weight loss [80]. A stepped-care model should be consid-
ered [82]. Therefore, we are planning to compare the re-
sults of the current study to other fertility clinics who have
less invasive (one or two-component) weight loss consult-
ation programs. This seems to be an ideal first step for the
future development of a stepped-care multicentre RCT.
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